Medis logo with tagline png
QFR® (Quantitative Flow Ratio)
QFR® is the innovative technology allowing for the non-invasive assessment of functional significant coronary lesions, without the use of adenosine or pressure wires. In addition detailed anatomical information is obtained that assists the healthcare professional in treatment decisions.
Request a Trial

Benefits

The novel and patented QFR® approach applies advanced mathematical modelling to accurately and effectively measure the physiologic and anatomical extent of a patient’s coronary artery disease. QFR® also improves the patient experience with fast procedure times, no invasive devices or adenosine administration is required.

General Benefits

  • Proven accuracy

QFR® is proven to have good correlation and agreement with FFR,
by 12.000+ patients and 15.000+ lesions in 110+ peer reviewed articles.

  • Time & Cost Efficiency

No pressure wire, no adenosine, reduces treatment costs and procedure time

  • User Friendly

Simpler Intuitive workflow, applicable for online and offline usage

Clinical Benefits

  • QFR® can be used for the assessment of the result post-PCI , thereby facilitating quality control
  • QFR® allows assessment of non-culprit lesions to decide on Yes or No staged procedure, potentially saving the second intervention procedure
Request a Demo

QFR® features

Image Acquisition

Simpler, Faster, Wireless Coronary Physiology – QFR 2.1

  • Automated Frame Counting for easier QFR analysis
  • Improved Contour Detection especially on low dose images
  • Improved Image export

Image Analysis

Automatic ED frame selection based on ECG

QFR® provides 2 different flow models:

  • Fixed flow QFR®, using fixed flow velocity
  • Contrast QFR® based on the contrast frame count

QFR® Results

  • 3D anatomic info for stent sizing
  • Allows prioritization of serial lesions
  • Residual QFR® predicts the effect of an intervention on the resulting QFR® value
  • User Lesion: Lesions can be combined by adding user lesion, so the lesions can be compared for optimal treatment planning
More information
  • More information
QFR Leaflet
QFR Pay Per Use

What our customers say

‘QFR is a simplified and cost effective way of functional testing without any potential for complications during testing’.
Dr. A. Sreenivas Kumar
Dr. A. Sreenivas KumarChairman Cardiovascular Sciences & Chief Cardiologist Citizens Hospital Nallagandla, Hyderabad, India
‘Since the installation of QFR in my cathlab, I no longer use wire FFR anymore’.
Dr. Jean Fajadet
Dr. Jean FajadetClinique Pasteur, Toulouse, France
‘QFR it is a robust technology and it provides good diagnostic data and guiding information’.
Dr. Niels Holm
Dr. Niels HolmAarhus University, Denmark
‘I’m a strong believer QFR adds invaluable parameters to the diagnostic angiogram. This will move us to one test that will give us all the information.’
Professor Andreas Baumbach
Professor Andreas BaumbachChair for Device Innovation, Queen Mary University of London, UK
'State-of-the-art approach in acute coronary syndrome targets on the ''pancoronary risk''. – This can be assessed easily, safely and reproducibly by QFR.'
Prof. Dr. Leistner
Prof. Dr. LeistnerCharité Berlin - Benjamin Franklin
Previous
Next

Newsletter

Subscribe to be the first informed about our latest news.

    All NewsQFR® NewsMR/CT News

    captcha

    Please enter the CAPTCHA code below and press “Send”.

    * = Required

    Medis logo transparent png white

    Medis Medical Imaging Systems BV
    Schuttersveld 9, 2316 XG Leiden
    P.O. Box 384, 2300 AJ Leiden, The Netherlands

    ©2021 Medis Medical Imaging Systems B.V. All rights reserved.
    Last updated: 08-12-2021